Jump to content
Wikipedia The Free Encyclopedia

Trenbolone hexahydrobenzylcarbonate

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Trenbolone hexahydrobenzylcarbonate
Clinical data
Trade names Parabolan, Hexabolan
Other namesTrenbolone cyclohexylmethylcarbonate; Estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate
Routes of
administration
Intramuscular injection
Drug class Androgen; Anabolic steroid; Androgen ester; Progestogen
Identifiers
  • Cyclohexylmethyl [(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] carbonate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.041.503 Edit this at Wikidata
Chemical and physical data
Formula C26H34O4
Molar mass 410.554 g·mol−1
3D model (JSmol)
  • C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)OCC5CCCCC5
  • InChI=1S/C26H34O4/c1-26-14-13-21-20-10-8-19(27)15-18(20)7-9-22(21)23(26)11-12-24(26)30-25(28)29-16-17-5-3-2-4-6-17/h13-15,17,22-24H,2-12,16H2,1H3/t22-,23+,24+,26+/m1/s1
  • Key:GQJSFWYQKNQCIK-APFRJGHOSA-N

Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.[1]

It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997.[1] [2] The drug acts as a long-lasting prodrug of trenbolone when administered via intramuscular injection.[1] It was used clinically at a dosage of one ampoule (76 mg, corresponding to 50 mg trenbolone base) every 10 days.[1]

See also

[edit ]

References

[edit ]
  1. ^ a b c d William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 619–. ISBN 978-0-9828280-1-4.
  2. ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia. Elsevier. pp. 3307–. ISBN 978-0-8155-1856-3.

Further reading

[edit ]
  • Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi:10.1016/j.steroids.2010年01月01日9. PMID 20138077. S2CID 205253265.
[edit ]


Androgens
(incl. AAS Tooltip anabolic–androgenic steroid)
AR Tooltip Androgen receptor agonists
Progonadotropins
Antiandrogens
AR Tooltip Androgen receptor antagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
Progestogens
(and progestins)
PR Tooltip Progesterone receptor agonists
Antiprogestogens
SPRMs Tooltip Selective progesterone receptor modulators
PR Tooltip Progesterone receptor antagonists
AR Tooltip Androgen receptor
Agonists
SARMs Tooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
PR Tooltip Progesterone receptor
Agonists
Mixed
(SPRMs Tooltip Selective progesterone receptor modulators)
Antagonists
mPR Tooltip Membrane progesterone receptor
(PAQR Tooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Stub icon

This article about a steroid is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

AltStyle によって変換されたページ (->オリジナル) /